Pharm 30 Endocrine Pancreas/Glucose Homeostasis Part I Flashcards
(40 cards)
alpha-glucosidase inhibitors (3)
acarbose
migitol
voglibose
Prandial Bolus Insulins (4)
"LAGeR" Insulin Lispro Insulin aspart Insulin glulisine Regular Insulin
Basal “ long acting “ insulins (3)
NPH insulin
insulin glargine
Insulin detemir
First generation sulfonylureas (4)
TACT tolbulamide acetohexamide chlorpropamide tolazamide
Second generation sulfonylureas (5)
G's Glimepiride Glipizide Glibenclamide Gliclazide Gliquidone
Meglitinides (2)
Nateglinide
Repaglinide
The biguanide (insulin sensitizer
Metformin
Amylin Analogue
Pramlintide
GLP-1 analoges
“El” GLP-1 analogues
Exenatide
Liraglutide
DPP-4 inhibitors
Sit-Sax (instead of the sitaur)
Sitagliptin
Saxagliptin
Thiazolidinediones (insulin sensitizers)
TZDs
Rosiglitazone
Somatostatin analogue
Octreotide
MOA: Bind avidly to intestinal brush border alpha glucosidase enzymes, slowing breakdown and absorption of dietary carbohydrates such as dextrin, and disaccharides
- alpha glucosidase inhibitors (acarbose, migitol, voglibose)
Contraindications Include cirrhosis, DKA, digestive problems, IBD, and Bowel obstruction
alpha-glucosidases
hypoglycemia is the sole CI for
Exogenous insulin
DKA is the sole CI for
Sulfonylureas
DKA + Type 1 diabetes are the CIs for
Meglitinides
Contraindications are metabolic acidosis, Hepatic disease, Renal impairment, Respiratory distress, Alcohol abuse, Septicemia, Heart failure
Metformin
What may result in a patient on Metformin that has received iodinated contrast media if acute alteration of renal function is an underlying issue ?
Lactic Acidosis
Hypoglycemia + Gastroparesis CI for
Pramlintide
ype 1 dm + DKA CI for
Incretins (GLP-1 analogues and DPP4 inhibitors
Heart failure is the sole CI for
TZDs
Patient with a pheochromocytoma cannot receive
exogenous glucagon
Type 2 dm and polycystic ovarian syndrom are indicated for use of
Metformin